Controlling gene drive in mosquito populations

Self-eliminating strategy to control gene drive

['FUNDING_R01'] · TEXAS A&M AGRILIFE RESEARCH · NIH-10846752

This study is exploring a new way to help control mosquito populations to reduce the spread of diseases like dengue and chikungunya, using a special technology that can make the mosquitoes eliminate themselves over time.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorTEXAS A&M AGRILIFE RESEARCH (nih funded)
Locations1 site (College Station, UNITED STATES)
Trial IDNIH-10846752 on ClinicalTrials.gov

What this research studies

This research investigates a novel method to control gene drives in mosquito populations, which could help reduce the transmission of diseases like dengue and chikungunya. By using CRISPR/Cas9 technology, the project aims to develop a self-eliminating transgene that can be introduced into mosquitoes and then programmed to remove itself from the population. The study will utilize both fruit flies and Aedes aegypti mosquitoes to evaluate the effectiveness of this self-elimination strategy. The research focuses on understanding the parameters that influence this system, ensuring it can be safely implemented in real-world environments.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living in regions affected by mosquito-borne diseases such as dengue and chikungunya.

Not a fit: Patients living in areas where these diseases are not prevalent may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective methods for controlling mosquito-borne diseases.

How similar studies have performed: While gene drive technologies have shown promise in other studies, this specific self-elimination approach is relatively novel and has not been extensively tested.

Where this research is happening

College Station, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Disease Vectors

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.